Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

Chemotherapeutic refractoriness of advanced cutaneous melanoma may be linked with melanoma-initiating cells, also known as melanoma stem cells. This study aimed to determine relative risk of clonal dominance of the CD133(+) phenotype in tissues from melanoma patients with different clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: SHARMA, BHUVNESH K., MANGLIK, V., O’CONNELL, MICHAEL, WEERARATNA, ASHANI, McCARRON, EDWARD C., BROUSSARD, JENNIFER N., DiVITO, KYLE A., SIMBULAN-ROSENTHAL, CYNTHIA M., ROSENTHAL, DEAN S., ZAPAS, JOHN L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583984/
https://www.ncbi.nlm.nih.gov/pubmed/22922842
http://dx.doi.org/10.3892/ijo.2012.1590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583984/
https://www.ncbi.nlm.nih.gov/pubmed/22922842
http://dx.doi.org/10.3892/ijo.2012.1590

Ejemplares similares